Barfresh director receives 5,798 shares as interest

Q: How many BRFH shares did director Joseph M. Cugine receive?

Joseph M. Cugine acquired 5,798 common shares on October 1, 2026, issued as interest payment on a convertible note and valued at $0.86 per share. His direct common-stock holdings after the transaction were 262,944 shares.

The convertible note lists 68,966 underlying shares and a $2.90 conversion price; the Series R warrant lists 62,500 underlying shares and a $3.20 exercise price.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Barfresh Food Group Inc. director Joseph M. Cugine acquired 5,798 common shares on October 1, 2026, issued as payment of interest on a convertible note and valued at $0.86 per share. His direct common-stock holdings after the transaction were 262,944 shares.

The reported positions also include a convertible note, a Series R warrant and stock options, with stated underlying share counts, prices and expiration dates.

Insider Trade Summary

Other: 5,798 shares

Other 6 txns

Insider Cugine Joseph M.

Role Director

Type	Security	Shares	Price	Value
Other	Common Stock ^F1	5,798	--	--
holding	10% Series A Convertible note	--	--	--
holding	Series R Warrant (Right to Buy)	--	--	--
holding	Stock options	--	--	--
holding	Stock options	--	--	--
holding	Stock options	--	--	--

Holdings After Transaction: Common Stock — 262,944 shares (Direct); 10% Series A Convertible note — 68,966 contracts (Direct); Series R Warrant (Right to Buy) — 62,500 contracts (Direct); Stock options — 44,186 contracts (Direct)

Footnotes (1)

F1. Shares issued as payment of interest on a convertible note, valued at $0.86 per share.

Key Figures

Common shares acquired: 5,798 shares Stated value per share: $0.86 per share Direct common shares following transaction: 262,944 shares +4 more

7 metrics

Common shares acquired 5,798 shares Issued as interest payment on October 1, 2026

Stated value per share $0.86 per share Shares issued as interest payment on a convertible note

Direct common shares following transaction 262,944 shares Joseph M. Cugine's reported position after the October 1, 2026 transaction

Convertible note underlying shares 68,966 common shares 10% Series A Convertible note

Conversion price $2.90 per share 10% Series A Convertible note

Series R Warrant underlying shares 62,500 common shares Series R Warrant (Right to Buy)

Warrant exercise price $3.20 per share Series R Warrant (Right to Buy)

Key Terms

10% Series A Convertible note, Series R Warrant (Right to Buy), Stock options

3 terms

10% Series A Convertible note financial

"10% Series A Convertible note"

Series R Warrant (Right to Buy) financial

"Series R Warrant (Right to Buy)"

Stock options financial

"Stock options"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many BRFH shares did director Joseph M. Cugine receive?

Joseph M. Cugine acquired 5,798 common shares on October 1, 2026, issued as interest payment on a convertible note and valued at $0.86 per share. His direct common-stock holdings after the transaction were 262,944 shares.

What convertible securities and options did Joseph M. Cugine report holding?

The reported positions include a 10% Series A Convertible note with 68,966 underlying common shares, a $2.90 conversion price and a March 6, 2028 expiration; a Series R Warrant with 62,500 underlying common shares, a $3.20 exercise price and a March 6, 2030 expiration; and three stock-option positions: 19,231 shares at $6.76 (expiring December 31, 2026), 5,724 at $5.46 (expiring May 7, 2029), and 19,231 at $7.15 (expiring December 31, 2026).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 10/02/2026 - 04:06 PM Accepted by SEC EDGAR 10/02/2026 - 04:05 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cugine Joseph M.

(Last)

(First)

(Middle)

500-14 MAIN STREET

(Street)

RIDGEFIELD

CONNECTICUT

06877

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
BARFRESH FOOD GROUP INC. [ BRFH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/01/2026		J		5,798	A	⁽¹⁾	262,944	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
10% Series A Convertible note	$2.9							03/06/2026	03/06/2028	Common Stock	68,966		$200,000	D
Series R Warrant (Right to Buy)	$3.2							03/06/2026	03/06/2030	Common Stock	62,500		62,500	D
Stock options	$6.76							07/26/2018	12/31/2026	Common Stock	19,231		19,231	D
Stock options	$5.46							05/07/2021	05/07/2029	Common Stock	5,724		5,724	D
Stock options	$7.15							09/15/2017	12/31/2026	Common Stock	19,231		19,231	D

Explanation of Responses:

1. Shares issued as payment of interest on a convertible note, valued at $0.86 per share.

	/s/ Joseph M. Cugine	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR